BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rusinkevich V, Huang Y, Chen ZY, Qiang W, Wang YG, Shi YF, Yang HT. Temporal dynamics of immune response following prolonged myocardial ischemia/reperfusion with and without cyclosporine A. Acta Pharmacol Sin 2019;40:1168-83. [PMID: 30858476 DOI: 10.1038/s41401-018-0197-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu S, Tang X, Zheng T, Li S, Ren H, Wu H, Peng F, Gong L. Plasma-derived extracellular vesicles transfer microRNA-130a-3p to alleviate myocardial ischemia/reperfusion injury by targeting ATG16L1. Cell Tissue Res 2022. [PMID: 35503135 DOI: 10.1007/s00441-022-03605-0] [Reference Citation Analysis]
2 Li Q, Wang J, Wu Q, Cao N, Yang HT. Perspective on human pluripotent stem cell-derived cardiomyocytes in heart disease modeling and repair. Stem Cells Transl Med 2020;9:1121-8. [PMID: 32725800 DOI: 10.1002/sctm.19-0340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
3 Peterson EA, Sun J, Wang J. Leukocyte-Mediated Cardiac Repair after Myocardial Infarction in Non-Regenerative vs. Regenerative Systems. J Cardiovasc Dev Dis 2022;9:63. [PMID: 35200716 DOI: 10.3390/jcdd9020063] [Reference Citation Analysis]
4 Van Nguyen TT, Vu NB, Van Pham P. Mesenchymal Stem Cell Transplantation for Ischemic Diseases: Mechanisms and Challenges. Tissue Eng Regen Med 2021;18:587-611. [PMID: 33884577 DOI: 10.1007/s13770-021-00334-3] [Reference Citation Analysis]
5 Sasaki T, Shimazawa M, Kanamori H, Yamada Y, Nishinaka A, Kuse Y, Suzuki G, Masuda T, Nakamura S, Hosokawa M, Minatoguchi S, Hara H. Effects of progranulin on the pathological conditions in experimental myocardial infarction model. Sci Rep 2020;10:11842. [PMID: 32678228 DOI: 10.1038/s41598-020-68804-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Li WW, Li D, Qin Y, Sun CX, Wang YL, Gao L, Ling-Hu L, Zhang F, Cai W, Zhu L, Wang G. Cardioprotective effects of Amentoflavone by suppression of apoptosis and inflammation on an in vitro and vivo model of myocardial ischemia-reperfusion injury. Int Immunopharmacol 2021;:108296. [PMID: 34794889 DOI: 10.1016/j.intimp.2021.108296] [Reference Citation Analysis]
7 Dehghani T, Thai PN, Sodhi H, Ren L, Sirish P, Nader CE, Timofeyev V, Overton JL, Li X, Lam KS, Chiamvimonvat N, Panitch A. Selectin-Targeting Glycosaminoglycan-Peptide Conjugate Limits Neutrophil Mediated Cardiac Reperfusion Injury. Cardiovasc Res 2020:cvaa312. [PMID: 33125066 DOI: 10.1093/cvr/cvaa312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Santos-Zas I, Lemarié J, Zlatanova I, Cachanado M, Seghezzi JC, Benamer H, Goube P, Vandestienne M, Cohen R, Ezzo M, Duval V, Zhang Y, Su JB, Bizé A, Sambin L, Bonnin P, Branchereau M, Heymes C, Tanchot C, Vilar J, Delacroix C, Hulot JS, Cochain C, Bruneval P, Danchin N, Tedgui A, Mallat Z, Simon T, Ghaleh B, Silvestre JS, Ait-Oufella H. Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun 2021;12:1483. [PMID: 33674611 DOI: 10.1038/s41467-021-21737-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 George TA, Hsu C, Meeson A, Lundy DJ. Nanocarrier-Based Targeted Therapies for Myocardial Infarction. Pharmaceutics 2022;14:930. [DOI: 10.3390/pharmaceutics14050930] [Reference Citation Analysis]
10 Fernandez Rico C, Konate K, Josse E, Nargeot J, Barrère-lemaire S, Boisguérin P. Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury. Front Cardiovasc Med 2022;9:792885. [DOI: 10.3389/fcvm.2022.792885] [Reference Citation Analysis]
11 Ravaud C, Ved N, Jackson DG, Vieira JM, Riley PR. Lymphatic Clearance of Immune Cells in Cardiovascular Disease. Cells 2021;10:2594. [PMID: 34685572 DOI: 10.3390/cells10102594] [Reference Citation Analysis]